Preoperative ChemoRadiation And FOLFOXIRI for Rectal Cancer (CRAFTER) for Rectal Cancer
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Patrick M Boland, MD
Rutgers Cancer Institute of New Jersey
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Rwjbarnabas Health - Monmouth Medical Center
Lakewood, New Jersey, United States
- Rwjbarnabas Health - Saint Barnabas Medical Center, Livingston
Livingston, New Jersey, United States
- Rutgers, the State University of New Jersey
New Brunswick, New Jersey, United States
- Rwjbarnabas Health - Robert Wood Johnson University Hospital, Somerset
Somerset, New Jersey, United States
- Rwjbarnabas Health - Community Medical Center
Toms River, New Jersey, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 13 May 2022
- Primary completion
- 30 Dec 2027
- Completion
- 30 Jan 2028
- Last update posted
- 4 Dec 2025
- Registered enrollment
- 38
- Registry id
- NCT05358704
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.